Image by boodoo via Flickr I found a nice list of all the drugs approved in 2009 and their respectable companies.
Those of note were Glaxo SmithKline (GSK) with HPV vaccine, H1N1, seasonal flu vaccine, renal carcinoma, and lymphocyte leukemia.
Novartis (NVS) for H1N1, seasonal flu vaccine, MS, malaria, and schizophrenia.
Schering-Plough, now Merck (MRK) , for schizophrenia. Schering was bought out for their extensive drug pipeline of numerous upcoming drugs.
Sanofi-Aventis (SNY) had an antiarrhythmic drug, along with another flu vaccine for elderly patients. Sanofi is getting snuffed out with the Genzyme takeover bid but the bidding could still continue.
Others included Takeda Pharmaceuticals (TKPHF), Cypress Biosciences/Forest Labs, Allos Therapeutics, Lilly/Daiichi Sankyo, Gloucester Pharmaceuticals, and Theravance.
I think these drugs have really propelled these companies even in a tough economic environment. All these stocks have had their ups and downs but these approvals will add to their portfolios when the economy recovers. They can be seen as performing today at a significant discount of true valuations of market capitalization. Buy low and sell high is always the rule.
Forest Labs (FRX) is especially promising with an upcoming FDA decision on Tuesday of this week.
Top Drugs of 2009 (If you click on the link or photo below it will open up as a larger image)